ARTICLE | Company News

Sheffield, Zambon Group SpA deal

January 8, 2001 8:00 AM UTC

SHM received a $1 million interest-free advance from Zambon for demonstrating the feasibility of delivering a steroid formulation using SHM's Metered Solution Inhaler. Under a 1998 agreement, the companies are developing the inhaler to treat respiratory diseases (see BioCentury, June 22, 1998). ...